Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

Cell metabolism | 2018

Sterile inflammation after tissue damage is a ubiquitous response, yet it has the highest amplitude in the liver. This has major clinical consequences, for alcoholic and non-alcoholic steatohepatitis (ASH and NASH) account for the majority of liver disease in industrialized countries and both lack therapy. Requirements for sustained sterile inflammation include increased oxidative stress and activation of the HIF-1α signaling pathway. We demonstrate the ability of digoxin, a cardiac glycoside, to protect from liver inflammation and damage in ASH and NASH. Digoxin was effective in maintaining cellular redox homeostasis and suppressing HIF-1α pathway activation. A proteomic screen revealed that digoxin binds pyruvate kinase M2 (PKM2), and independently of PKM2 kinase activity results in chromatin remodeling and downregulation of HIF-1α transactivation. These data identify PKM2 as a mediator and therapeutic target for regulating liver sterile inflammation, and demonstrate a novel role for digoxin that can effectively protect the liver from ASH and NASH.

Pubmed ID: 29414684 RIS Download

Associated grants

  • Agency: NIAAA NIH HHS, United States
    Id: U01 AA021912
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001863
  • Agency: NIAAA NIH HHS, United States
    Id: U01 AA021908
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK110181
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK092606
  • Agency: NIA NIH HHS, United States
    Id: R01 AG060726
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK034989
  • Agency: NIDDK NIH HHS, United States
    Id: R56 DK076674
  • Agency: NIAAA NIH HHS, United States
    Id: U01 AA020821
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK108283
  • Agency: BLRD VA, United States
    Id: I01 BX000289
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK083283
  • Agency: NIDDK NIH HHS, United States
    Id: K08 DK092281
  • Agency: BLRD VA, United States
    Id: I01 BX003259

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GraphPad (tool)

RRID:SCR_000306

A commercial graphing software company that offers scientific software for statistical analyses, curve fitting and data analysis. It offers four programs: Prism, InStat, StatMate and QuickCalcs.

View all literature mentions

anti-NLRP3/NALP3 mAb (Cryo-2) (antibody)

RRID:AB_2490202

This monoclonal targets NLRP3/NALP3

View all literature mentions

caspase-1 p10 (M-20) (antibody)

RRID:AB_2068895

This polyclonal targets caspase-1 p10

View all literature mentions